Neurocognitive Function and Its Related Potentials in Children with Beta Thalassemia Major: An Egyptian Study by El-Alameey, Inas R. et al.
 
Open Access Maced J Med Sci electronic publication ahead of print,  
published on January 16, 2019 as https://doi.org/10.3889/oamjms.2019.077 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                          1 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 
https://doi.org/10.3889/oamjms.2019.077 
eISSN: 1857-9655 
Clinical Science 
 
 
  
 
Neurocognitive Function and Its Related Potentials in Children 
with Beta Thalassemia Major: An Egyptian Study 
 
 
Inas R. El-Alameey
1*
, Fatma Alzaree
1
, Manal A. Shehata
1
, Mones M. Abu Shady
1
, Mohamed Abdel Atti
1
, Mohamed I. El-
Khonezy
2
 
 
1
Child Health Department, Medical Research Division, National Research Centre, Egypt; 
2
Molecular Biology Department, 
Genetic Engineering and Biotechnology Division, National Research Centre, Egypt 
 
Citation: El-Alameey IR, Alzaree F, Shehata MA, Abu 
Shady MM, Abdel Atti M, El-khonezy MI. Neurocognitive 
Function and Its Related Potentials in Children with Beta 
Thalassemia Major: An Egyptian Study. Open Access 
Maced J Med Sci. 
https://doi.org/10.3889/oamjms.2019.077 
Keywords: β-Thalassemia; Neurocognitive; Children; 
Egyptian; Potentials 
*Correspondence: Inas R. El-Alameey. Child Health 
Department, Medical Research Division, National 
Research Centre, P.O 12622 Egypt. Affliation ID: 
60014618.  E-mail: inasno@hotmail.com 
Received: 09-Nov-2018; Revised: 20-Nov-2018; 
Accepted: 29-Nov-2018; Online first: 16-Jan-2019 
Copyright: © 2019 Inas R. El-Alameey, Fatma Alzaree, 
Manal A. Shehata, Mones M. Abu Shady, Mohamed 
Abdel Atti, Mohamed I. El-Khonezy. This is an open-
access article distributed under the terms of the Creative 
Commons Attribution-NonCommercial 4.0 International 
License (CC BY-NC 4.0) 
Funding: The study was a part of a project supported 
financially by National Research Centre Egypt (Grant No. 
11010145) 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
 
Abstract 
BACKGROUND: Repeated blood transfusions and hemolysis in β-Thalassemia major children lead to iron 
overload in various organs, including the brain which may cause neurodegeneration. 
AIM: To evaluate intelligence quotient in children with β-thalassemia major and healthy counterparts and to 
assess risk factors that cause cognitive problems. 
SUBJECTS AND METHODS: This case-control study was performed on 50 children aged 6-16 years old with β-
thalassemia major as patients group and compared with 50 healthy children as a control group of matched age, 
sex, and social class. Cognitive functions were evaluated by using the Wechsler Intelligence Scale for Children. 
Serum ferritin and iron were measured by ELISA. 
RESULTS: There were significantly lower mean performance and full-scale IQ scores of patients group in 
comparison with controls, whereas no significant differences between both groups as regards to a verbal IQ 
score. In thalassemic children, block design, comprehension and arithmetic were negatively correlated with age of 
disease onset, duration of illness and onset of chelation therapy. Serum iron and ferritin were negatively 
correlated with similarities and digit span. Serum iron levels were negatively correlated with performance IQ 
score. 
CONCLUSION: Children with β-thalassemia major need to receive more academic attention and cognitive 
assessment to improve their IQ. 
 
 
 
 
 
Introduction 
 
β-Thalassemia major is a chronic hematologic 
disease of a genetic basis that is characterised by 
ineffective erythropoiesis, peripheral hemolysis, and 
severe anaemia [1]. It is the commonest chronic 
hemolytic anaemia in Egypt (85.1%), with a carrier 
rate about 9% to 10.2% from an examination of 1000 
normal random subjects from different geographic 
areas of the country [2].  
The affection of the nervous system in those 
patients can be attributed to many factors acting as 
several cumulative small injuries to the central 
nervous system over many years such as hemolysis 
and repeated blood transfusions which lead to a 
decrease in nitric oxide levels and iron overload in 
several organs, including the brain. Also, increased 
iron in the brain leads to oxidative stress and possible 
irreparable brain tissue damage, causing cognitive 
impairment [3], [4]. Thalassemic patients are 
dependent on regular blood transfusion to decrease 
complications of anaemia and expand bone marrow 
[5]. This repeated blood transfusion is associated with 
excessive iron absorption [6], iron overload, chronic 
hypoxic state; in addition to neurotoxicity due to 
lifelong chelating therapy (deferoxamine). All of these 
factors lead to brain dysfunction [7], [8]. Metafratzi et 
al., [9] stated that there was high iron deposition in the 
putamen, caudate nucleus, motor and temporal cortex 
of patients with β-Thalassemia major. These areas 
are extremely important for cognitive function as for 
implicit and explicit memory. Other risk factors for 
brain damage include transient ischemic attacks, 
asymptomatic brain infarcts and visual and auditory 
toxicity of deferoxamine [10]. In another study, 
Economou et al., [11] demonstrated subclinical 
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involvement of central and peripheral neural pathways 
in β-Thalassemia major patients and recommended 
regular intellectual monitoring using the Wechsler 
Intelligence Scale, for early detection of any 
intellectual dysfunction in young β-Thalassemia major 
patients [12]. Therefore, this study aimed to evaluate 
the neurocognitive function in β-thalassemia major 
patients and recognising the correlation between 
possible neurocognitive dysfunction and various 
clinical parameters as the age of disease onset, the 
frequency of blood transfusion, iron chelating drugs, 
and serum ferritin, iron, and haemoglobin 
concentration of the patients. 
 
 
Subjects and Methods 
 
Subjects 
A descriptive case-control study was 
conducted in the outpatient Child Health Clinic in 
Centre of Medical Excellence, National Research 
Center, Egypt, throughout 8 months. One hundred 
children; 50 children with b-thalassemia major (25 
boys, and 25 girls; mean age, 9.57 ± 1.33 years; 
range, 6-16 years), were enrolled into this study and 
referred from the Pediatric Clinical Hematology 
Outpatient Clinic at Ain Shams University Hospital in 
Egypt. They were compared with a group of 50 
healthy children with matched age, sex, educational 
level, parental education, and years of schooling, and 
socioeconomic level, which were cognitively and 
neurologically normal, acting as healthy volunteers. 
Their past medical history and clinical examination 
were revised for confirmation of being and their first-
degree relatives completely free of any chronic 
disorders, including thalassemia. 
The inclusion criteria comprised of children 
diagnosed with β-thalassemia major aged between 6-
16 years with regular blood transfusions and iron 
chelation treatment, formal education, and no fever. 
The exclusion criteria were as follows: (a) had history 
of major mental disorders with delayed milestone 
development; (b) had physical disabilities that could 
interfere with performance, such as deafness or 
blindness; (c) had received prior treatment with drugs 
known to be neurotoxic; or (d) had history of chronic 
medical illness other than thalassemia that could 
affect cognition. Children in β-thalassemia major 
group were receiving blood once a month regularly to 
maintain their haemoglobin concentration at more 
than 9 gm/dl level, and they were taking deferoxamine 
as medication. 
Written informed consent was taken from all 
patients’ guardians before participation in the study 
and after complete explanation of their task in the 
research. The consent was approved by the Ethical 
Committee of the National Research Center and Ain 
Shams University under the registration number 
16358. 
 
Clinical assessment and anthropometric 
measurements 
Full medical history, complete data on 
transfusion and chelation regimens were taken from 
all patients. Clinical examination was performed with 
special emphasis on disease-related complications 
and chelation therapy-related side effects. 
Anthropometric measurements including weight, 
height, and head circumferences were assessed for 
all the studied subjects at the National Research 
Centre. Calculation of the body weight was done to 
the nearest 0.1 kg by a standard clinical balance. 
Measuring standing body height was done to the 
nearest 0.1 cm by using Holtain Stadiometer. 
Recalibration of all scales took place after each 
measurement following the recommendations of the 
International Biological Program [13]. Calculation of 
the subjects’ body mass index (BMI) was done by 
using the formula of weight/height
2
 (kg/m
2
). 
 
Laboratory investigation 
After an overnight fast, venous blood samples 
were withdrawn from all participants and the 
separated sera were stored at −20°C. Routine 
laboratory investigations were done for thalassemic 
patients according to international standards, 
including complete blood picture, serum ferritin, and 
iron using enzyme-linked immunosorbent assay 
ELISA kit obtained from Glory Bioscience, (USA), 
according to manufacturer’s manual. 
 
Neuropsychological testing 
All the patients and controls were subjected to 
IQ evaluation by using the Arabic version of the 
Wechsler Intelligence Scale for Children-Third Edition, 
(WISC-R) [14]. This test assesses the intelligence of 
children in three scales of full IQ, verbal IQ and 
performance IQ. Full-scale IQ is based on 10 tests 
incorporated in the verbal and performance (non-
verbal) IQ scales. The administration time for the test 
was approximately 60 to 90 minutes. The child was 
allowed to complete the test in 2 separate sessions. 
Verbal IQ is based on information, similarities, 
arithmetic, comprehension and digit span. The 
comprehension subtest is a scale of the student's 
social knowledge and the depth of development of 
morals. Similarities subtest is a measure of logic, 
abstract thinking and verbal reasoning, while 
information is a scale of general knowledge, 
education, and long-term memory of his experience. 
Arithmetic and digit span subtests are measures of 
working, short, and long-term memory. 
Performance (non-verbal) IQ is based on 
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picture completion, coding, picture arrangement, block 
design and object assembly. Block design measures 
the ability to analyse and synthesise an abstract 
design, and production of the design from coloured 
plastic. The Picture completion subtest is a measure 
of a student's capability of recognising closely related 
items. The Object Assembly subtest is a measure of 
the ability of visualisation of item parts of Mazes. The 
mazes subtest measures perceptual organisation, 
visual-motor coordination, and self-control.  
 
Interpretation of IQ Score 
The IQ was graded based on the following 
guidelines:  
- 130 and higher: very superior; 
- 120-129: superior; 
- 110-119: high average; 
- 90-109: average; 
- 80-89: low average; 
- 70-79: borderline; 
- 69 and lower: extremely low. 
 
Statistical Analysis 
 SPSS version 22 (SPSS Inc, Chicago) was 
used to enter, check and analyse data. Results were 
expressed as mean ± standard deviation (SD) for 
quantitative variables and as number and percentage 
for qualitative ones. Based on the calculated required 
sample size, our study included 50 subjects with β-
thalassemia major. The marked differences in means 
for IQ between patients and controls and between 
males and females were analysed by unpaired 
Student t-test. Association between qualitative 
variables was done using a Chi-Squared test. 
Correlation between IQ and other parameters were 
investigated using Pearson coefficient of correlation. A 
p-value < 0.05 was considered significant and p < 
0.01 was considered highly significant. 
 
 
Results 
 
The education level, school performance and 
disease complications of the two groups are shown in 
Table 1. In the present study, all candidates were 
between 6 and 16 years old. Both patients and control 
groups were matched as regards their age, sex, 
educational level, parental education, and 
socioeconomic status. Lower school performance, 
growth retardation, and positive family history of 
thalassemia were significantly more common in the 
patient's group compared to the control group. 
Thalassemic patients had disease complications in 
the form of splenectomy that was present in 32%, 
hemosiderosis in 46%, hypogonadism in 28%, and 
hypoparathyroidism in 16%. 
Table 1:  Education level, school performance and disease 
complications of the two groups 
                               
                                    Variables 
Patients 
group 
N (%) 
Control 
group 
N (%) 
Education level Uneducated 4 ( 8%) 4 (8%) 
 Read and write only 8 (16%) 13 (26%) 
 Educated 38 (76%) 33 (66%) 
School performance Poor 18 (36%) 15 (30%) 
 Average 22 (44%) 17 (34%) 
 Above average 10 (20%) 18 (36%) 
Disease complications Positive family history  30 (60%) 0 (0%) 
Positive consanguinity 29 (58%) 0 (0%) 
Bone fracture 24 (48%) 8 (16%) 
Splenectomy 16 (32%) 0 (0%) 
Mongoloid facies 15 (30%) 0 (0%) 
Hemosidrosis 23 (46%) 0 (0%) 
Growth retardation 21 (42%) 6 (12%) 
Hypogonadism 14 (28%) 0 (0%) 
Hypoparathyroidism 8 (16%) 0 (0%) 
Hypothyroidism 25 (50%) 0 (0%) 
 
In thalassemic patients group, the mean age 
at onset of symptoms was 7 ± 1.4 months, and the 
mean duration of illness was 9.89 ± 4.4 years. The 
mean frequency of blood transfusion per year is 4.08 
± 1.31times and range from 2 to 8 years. The mean 
duration of chelation therapy is 9.16 ± 4.43 years. 
Eighty-four per cent of the patients were on chelation 
therapy, in the form of deferoxamine as shown in 
Table 2. 
Table 2: Clinical characteristics of the studied patients 
Variables Range 
Patients group 
Mean ± SD 
Age (years) 6-16 11.05 ± 3.83 
Age at onset ( months) 6-8 7 ± 1.4 
Duration of illness (years) 2-15 9.89 ± 4.30 
Duration of chelation therapy (years) 6-16 9.16 ± 4.43 
The frequency of blood transfusion per year 2-8 4.08 ± 1.31 
 
The mean and standard deviation of the age 
of children with β-thalassemia major was 9.57 ± 1.33, 
and that of the healthy children was 9.5 ± 1.31. In 
thalassemic patients group, the mean weight, and BMI 
(P < 0.01) were significantly lower compared to the 
control group. The mean serum levels of iron, and 
ferritin (P < 0.01) were significantly higher, while 
haemoglobin concentration (P < 0.01) was 
significantly lower compared to the control group as 
shown in Table 3. 
Table 3: Comparison of anthropometric measures and 
laboratory investigations of patients group and control group 
Variables 
Control group 
Mean ± SD 
Patients group 
Mean ± SD 
t-test P-value 
Age (years) 9.5 ± 1.31 9.57 ± 1.33 0.36 0.24 
Weight (kg) 44.18 ± 15.54 30.64 ± 11.15 -5.006 0.000** 
Height (cm) 139.46 ± 15.07 134.62 ± 17.12 -1.5 0.137 
BMI 22.18 ± 5.39 16.52 ± 2.69 -6.638 0.000** 
Head circumference (cm) 52.62 ± 1.7 52. 28 ± 2.78 0.346 0.73 
Hb concentration (gm/dl) 12.96 ± 1.12 11.024 ± 2.16 -3.334 0.001** 
Serum ferritin (ng/ml)  142.44 ± 69.66 2453.36 ± 1297.12 12.580 0.000** 
Serum iron (mcg/dl) 94.20 ± 32.16 233.09 ± 67.47 13.138 0.000** 
*Significant difference at p < 0.05; **highly significant difference at p ≤ 0.01. 
 
The mean performance IQ score (86.10 ± 
20.13) of cases (P < 0.01) are significantly less than 
those of controls (100.98 ± 7.06), and the mean total 
IQ score (92.86 ± 17.72 and 101.42 ± 6.47, 
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respectively; P < 0.05; whereas there is no significant 
difference among patients group and control group as 
regards to verbal IQ score (100.10 ± 16.49, and 
102.30 ± 6.98, respectively; P > 0.05). The mean 
scores of comprehensions, similarities, digit span 
tests (verbal IQ subsets) of patients group are 
significantly lower than those of controls. The object 
assembly, coding, and mazes (performance IQ 
subsets) of patients group are significantly lower than 
those of controls. Comparison of verbal, performance, 
and full IQ scores and its subsets between patients 
group and control group are presented in Table 4. 
Table 4: Comparison of IQ scores and its subsets between 
patients group and control group 
Variables 
Control group 
(N = 50) 
Patients group 
(N = 50) t-test P value 
Mean ± SD Mean ± SD 
Verbal IQ scores 102.30 ± 6.98 100.10 ± 16.49 -0.869 0.387 
Information 9.72 ± 3.57 9.96 ± 1.71 -0.429 0.669 
Comprehension 12.50 ± 4.86 10.70 ± 1.94 2.433 0.017* 
Arithmetic 7.60 ± 3.37 7.54 ± 2.27 0.104 0.917 
Similarities 11.60 ± 3.61 10.16 ± 1.83 2.513 0.014* 
Digit span 5.84 ± 2.98 4.76 ± 1.66 2.239 0.027* 
Performance IQ scores 100.98 ± 7.06 86.10 ± 20.13 -4.932 0.000** 
Picture completion 8.02 ± 2.06 7.70 ± 3.01 -0.622 0.536 
Block design 6.88 ± 3.27 6.28 ± 1.45 -1.186 0.239 
Object assembly 6.82 ± 0.87 5.70 ± 3.41 -2.252 0.027* 
Coding 10.20 ± 2.88 7.68 ± 4.78 -3.194 0.002** 
Mazes 10.32 ± 1.88 8.98 ± 4.22 -2.053 0.043* 
Full IQ  scores 101.42 ± 6.47 92.86 ± 17.72 -3.209 0.002** 
*Significant difference at p < 0.05; **highly significant difference at p ≤ 0.01. 
 
A significant difference exists between males 
and females groups as regards digit span and mazes 
(P < 0.01). No significant difference present among 
male and female patients in other verbal performance, 
full IQ scores, and other IQ subtests (P > 0.05) as 
demonstrated in Table 5. 
Table 5: Comparison between males and females as regard to 
IQ scores in patients group 
   
Variables 
Males Females t-test P value 
Mean ± SD Mean ± SD   
Verbal IQ scores 101.08 ± 17.71 99.12 ± 15.48 0.417 0.679 
Information 10.00 ± 4.12 9.44 ± 2.97 0.551 0.584 
Comprehension 13.32 ± 5.09 11.68 ± 4.57 1.199 0.236 
Arithmetic 8.12 ± 3.32 7.08 ± 3.04 1.094 0.280 
Similarities 11.76 ± 3.88 11.44 ± 3.4 0.310 0.758 
Digit span 6.68 ± 3.08 5.00 ± 2.68 2.059 0.045* 
Performance IQ scores 87.04 ± 20.42 85.16 ± 20.21 0.327 0.745 
Picture completion 8.12 ± 3.47 7.28 ± 2.46 0.988 0.328 
Block design 6.72 ± 3.62 5.84 ± 2.88 0.950 0.347 
Object assembly 5.80 ± 3.77 5.60 ± 3.07 0.206 0.838 
Coding 7.52 ± 4.16 7.84 ± 5.41 0.234 0.816 
Mazes 10.16 ± 4.54 7.80 ± 3.57 2.042 0.047* 
Full IQ scores  93.76 ± 18.82 91.96 ± 16.89 0.356 0.723 
*Significant difference at p < 0.05. 
 
Three patients (6%) were superior, (8%) of 
patients with high average full IQ scores, (34%) 
average, (22%) patients with low average, and (14%) 
patients with extremely low full IQ scores as shown in 
Table 6.  
Table 6: Distribution of IQ grades among the patient's groups 
Variable 
 
Very 
superior 
Superior High 
average 
Average Low 
average 
Borderline Extremely 
low 
Full IQ scores 
 
0 (%) 3 (6%) 4 (8%) 17 (34%) 11 (22%) 8 (16%) 7 (14%) 
 
In thalassemic children, block design (one of 
performance IQ subsets), and comprehension and 
arithmetic (some verbal IQ subsets) were negatively 
correlated with age of disease onset, duration of 
illness and chelation therapy. No significant 
correlation is found between IQ scores (Verbal, 
performance, and full-Scale) and frequency of 
transfusion as shown in Table 7. 
Table 7: Correlation between cognitive variables with some 
clinical variables 
Variables 
Age of 
disease 
onset 
Duration 
of 
illness 
Duration 
of chelation 
therapy 
The 
frequency of 
blood 
transfusion/
year 
Verbal IQ score 
Pearson correlation 0.052 0.037 0.053 -0.089 
P- value 0.719 0.799 0.717 0.537 
Information 
Pearson correlation 0.007 -0.021 -0.011 0.014 
P- value 0.962 0.887 0.938 0.925 
Comprehension 
Pearson correlation -0.406** -0.379** -0.382** -0.023 
P- value 0.003 0.007 0.006 0.877 
Arithmetic 
Pearson correlation -0.374** -0.387** -0.366** -0.099 
P- value 0.007 0.006 0.009 0.493 
Similarities 
Pearson correlation 0.114 0.090 0.102 -0.127 
P- value 0.431 0.533 0.480 0.379 
Digit span 
Pearson correlation -0.161 -0.214 -0.205 0.182 
P- value 0.265 0.136 0.153 0.207 
Performance IQ 
score  
Pearson correlation -0.159 -0.196 -0.180 -0.017 
P- value 0.271 0.174 0.212 0.909 
Picture 
completion 
Pearson correlation 0.000 -0.095 -0.087 0.162 
P- value 0.998 0.512 0.549 0.261 
Block design 
Pearson correlation -0.411** -0.475** -0.459** -0.034 
P- value 0.003 0.000 0.001 0.815 
Object 
assembly 
Pearson correlation -0.077 -0.137 -0.128 -0.132 
P- value 0.596 0.344 0.376 0.361 
Coding 
Pearson correlation -0.133 -0.210 -0.196 -0.205 
P- value 0.357 0.144 0.172 0.153 
Mazes 
Pearson correlation 0.027 0.006 0.005 0.108 
P- value 0.851 0.967 0.975 0.457 
Full IQ score 
Pearson correlation -0.092 -0.117 -0.099 -0.045 
P- value 0.525 0.418 0.493 0.755 
**Highly significant difference at p ≤ 0.01. 
 
Anthropometric measures as weight, and 
height were positively correlated with some verbal IQ 
subsets as comprehension and arithmetic as well as 
block design (one of performance IQ subsets). BMI is 
positively correlated with performance IQ and some of 
its subsets as block design and coding as well as 
some verbal IQ subsets as comprehension and 
arithmetic. Head circumference was positively 
correlated with arithmetic (verbal IQ subset), and 
coding (performance IQ subset). There were 
significant negative correlations between serum 
ferritin levels and comprehension, similarities, and 
digit span (some of the verbal IQ subsets). Serum 
total iron was negatively correlated with a 
performance IQ score, similarities, and digit span 
(some of the verbal IQ subsets). Haemoglobin 
concentration was positively correlated with digit span 
(verbal IQ subset), and object assembly (performance 
IQ subset) as shown in Table 8. 
 
 
Discussion 
 
Multiple risk factors contribute to cognitive 
impairment in β-thalassemia major patients [15]. 
Duman et al., [12], Vichinsky et al., [16] denoted the 
involvement of the nervous system in b-thalassemia 
major patients. They attributed the neurological 
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problems to several causes as iron overload, bone 
marrow expansion, chronic hypoxia and 
desferrioxamine neurotoxicity in thalassemia patients.  
In our study, a positive family history of β-
thalassemia major was present in 60%, and positive 
consanguinity in 58%. Disease complications in 
thalassemic patients were found in the form of 
splenectomy that was present in 32%, growth 
retardation in 26%, hemosiderosis secondary to long 
term blood transfusion in 46%, hypogonadism 28%, 
and hypoparathyroidism in 16%. These findings were 
in agreement with Egyptian study done by Raafat et 
al., [17] who reported growth retardation in 42%, 
hemosiderosis in 46%, hypogonadism in 22%, and 
hypoparathyroidism in 6%, hypothyroidism in 4%, 
cardiac complication in 6%. 
Ferritin is a protein that stores iron and exists 
in all tissues including the brain. Serum ferritin level is 
a good marker for assessing body iron stores [18]. In 
our study, the mean levels of serum iron, and ferritin 
were markedly higher, while haemoglobin 
concentration was significantly lower in thalassemic 
patients group in comparison to control group. These 
results come in agreement with the previous study by 
Fadlyana et al., [19] who assessed patients with beta-
thalassemia major, registered at 2 different centres of 
Rawalpindi and Islamabad. They stated that the 
majority of patients demonstrated very high ferritin 
levels, in which 76% of patients had values above 250 
mg/L. The high level of ferritin in beta-thalassemia can 
be attributed to repeated blood transfusions, 
ineffective erythropoiesis, and increased 
gastrointestinal iron absorption which causes iron 
overload in the body. 
Thalassemia can affect growths in the fetal, 
infancy, pre-puberty and puberty periods [20]. The 
principal cause of growth disorders in β-thalassemia 
major patients are influenced by many factors and still 
debated [21]. High serum ferritin levels and iron 
overload in puberty were reported to cause short 
stature and delayed body growths in thalassemia 
major patients [22]. Iron overload can prohibit bone 
metabolisms leading to growth disorders [23], [24]. In 
our present study, as thalassemia is a chronic form of 
anaemia, the weight difference is expected compared 
to control. The anthropometric measures as weight 
and BMI were affected and significantly lower in 
thalassemic patients compared to controls (P < 0.01). 
Our study analyzed the intelligence quotient 
of β-thalassemia major patients and healthy peers in 
terms of full, verbal and performance scales of IQ 
using 10 subscales of Wechsler IQ test for children 
and demonstrated that β-thalassemia major patients 
had marked lower performances and full-Scale IQ 
scores compared to controls; while, there was no 
difference in Verbal IQ between patients and controls. 
These results were compatible with Egyptian study 
done by Raafat et al., [17] who found marked lower 
performances and full-scale IQ scores and no 
apparent variations in verbal IQ scores in thalassemic 
patients’ group in comparison to control group. In 
another study, Economou et al., [11] studied the IQs 
of children with β-thalassemia major using WISC III 
and said that those children had higher scores on the 
verbal scale than Full and performance scales, and 
claimed that β-thalassemia probably had increased 
impairments in cognitive performance. These results 
about higher verbal scale scores are also similar to 
our results. 
Our results partly came in agreement with 
those of other studies that reported impairment of full-
scale IQ (including both verbal and performance 
components) in children with β-thalassemia major. 
Duman et al., [12] had evaluated cognitive function in 
20 children with β-thalassemia major and 21 healthy 
controls and found that Full-Scale IQ, verbal IQ, and 
performance IQ (P < 0.05) were markedly lower in the 
patients. In another study, Monastero et al., [25] 
assessed cognitive function in 46 β-thalassemia major 
patients and 46 controls of matching age, sex, and 
education and found that the β-thalassemia major 
patients, particularly those having signs of 
hemosiderosis, were profoundly affected on all 
neuropsychological tests. However, our results were 
not in agreement with Vichinsky et al., [16] as regards 
the verbal scale. Conversely, Karimi et al., [26] stated 
that there is no significant difference in IQ between 
patients of β-thalassemia major and controls. Again, 
Khairkar et al., [27] reported normal IQ in β-
thalassemia major patients. 
In our present study, the mean scores of 
comprehensions, similarities, digit span tests (verbal 
IQ subsets) of patients group are markedly lower than 
those of controls. The object assembly, coding, and 
mazes (performance IQ subsets) of patients group are 
significantly lower in comparison to those of controls. 
These findings agreed with Homayouni et al., [28], 
who reported that the verbal IQ subsets of β-
thalassemic children were significantly lower than that 
of healthy group in terms of information, arithmetic, 
comprehension, digit span, and the performance IQ 
subsets as picture completion, symbol search and 
mazes subscales of β-thalassemic children were 
significantly lower than that of healthy controls.  
In our study, three patients (6%) were 
superior, (8%) of patients had high average full IQ 
scores, (34%) average, (22%) patients with low 
average, and (14%) patients with extremely low full IQ 
scores. Canatan et al., [29] reported that academic 
problems were found in 60% of a sample population 
of thalassemic children. These findings suggest that 
there is a little caring about the quality of education of 
those children.  
Economou et al., [11] who demonstrated no 
association between gender of the patients and 
abnormal IQ in β-thalassemia major. In our study, 
there was a marked difference between male and 
female groups as regards digit span and mazes (P < 
Clinical Science   
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0.01); but, there was no marked difference between 
gender of the patients and other verbal IQ, 
performance IQ, and full-scale IQ subtests.  
This study discovered a positive correlation 
between weight and height with some verbal IQ 
subsets as comprehension and arithmetic as well as 
block design (one of performance IQ subsets). Body 
mass index (BMI) is positively correlated with 
performance IQ and some of its subsets as block 
design and coding as well as some verbal IQ subsets 
as comprehension and arithmetic. Head 
circumference was positively correlated with 
arithmetic (one of the verbal IQ subsets), and coding 
(one of performance IQ subsets). To our knowledge, 
the association between anthropometric measures as 
weight, height, BMI, head circumferences and 
abnormal IQ scores in the patients of β-thalassemia 
major has not yet been investigated. 
In our study, the influence of age of onset of 
symptoms, frequency of blood transfusion/ year, 
duration of illness, and chelation therapy and the 
effect of concentration of haemoglobin, serum iron, 
and ferritin levels on IQ scores of the patients were 
also examined. The reasonable clarification for lower 
mean performance IQ in our study, in comparison to 
that of verbal IQ, comes from the study of Ai et al., 
[18] on 171 Chinese children who found that children 
with low haemoglobin concentration had marked lower 
scores in performance IQ but not in verbal IQ. They 
explained this by that the low Hb concentration could 
have affected the brain areas that are responsible for 
performance IQ components during the critical stage 
of development in early childhood. This explanation 
can be applied to patients of β-thalassemia major who 
suffered from severe anaemia in their early childhood.  
In our study, there were significant negative 
correlations between serum ferritin levels and 
comprehension, similarities, and digit span (some of 
the verbal IQ subsets). Serum total iron was 
negatively correlated with a performance IQ score, 
similarities, and digit span (some of the verbal IQ 
subsets). Haemoglobin concentration was positively 
correlated with digit span (verbal IQ subset), and 
object assembly (performance IQ subset). These 
findings agreed with Duman et al., [12] and Vichinsky 
et al., [16] who found a marked negative correlation 
between serum ferritin concentrations with some 
cognitive function. These findings can be attributed to 
marked erythropoiesis and hemolysis. On the contrary 
with our study, Shehata et al., [30] stated that there is 
no important correlation between IQ (verbal, 
performance, and full-scale) and age of onset of 
transfusion, onset of chelation therapy, chelation 
compliance, and serum ferritin levels. Besides, there 
was no marked correlation between IQ and chelation 
therapy type.  
 In our study, abnormal block design (one of 
performance IQ subsets), and comprehension and 
arithmetic (some verbal IQ subsets) were negatively 
correlated with age of disease onset, duration of 
illness and onset of chelation therapy in thalassemic 
children. No significant correlation is found between 
IQ scores (verbal, performance, and full-Scale) and 
frequency of transfusion. Our results were not 
compatible with Economou et al., [11] who claimed no 
significant relation between abnormal IQ in β-
thalassemia major patients and serum ferritin levels, 
the age of onset of symptoms, the onset of 
transfusion, the onset of chelation therapy, chelation 
compliance, type of chelation therapy, and disease 
complications.  
In conclusion, this study concluded that 
performance IQ, not verbal IQ is significantly affected 
in the studied children with β-thalassemia major being 
affected by long duration of illness, and the onset of 
chelation therapy, and high serum ferritin and iron 
levels. Cognitive assessment is easy to be done, and 
β-thalassemia major children with learning problems 
need to receive more academic attention in order to 
improve their performance IQs.  
Recommendation: Intelligence quotient tests 
should be a part of routine comprehensive care of β-
thalassemia major patients especially cases of 
learning difficulties to detect cases that suffering from 
verbal or performance dysfunction and to be subject 
to the learning skills development program. 
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